Literature DB >> 7134230

A new subcutaneously-implantable reservoir for sustained release of nicotine in the rat.

C K Erickson, S A Stavchansky, K I Koch, J W McGinity.   

Abstract

A subcutaneously-implantable reservoir for the sustained release of nicotine is described. The device, dubbed INR for Implantable Nicotine Reservoir, is a small glass cup sealed with Silastic polymer. It releases 3.4 mg of nicotine per 24 hours. When implanted into moderately-sized female Sprague-Dawley rats it produces blood nicotine levels of 400-500 ng/ml which remain relatively stable over at least 18 days. INRs are nontoxic, reproducible, inexpensive, and adaptable for pharmacological and toxicological studies in rats and other small animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7134230     DOI: 10.1016/0091-3057(82)90067-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Chronic nicotine treatment changes differentially the effects of acute nicotine on the three main dopamine metabolites in mouse striatum.

Authors:  T Leikola-Pelho; J Heinämäki; I Laakso; L Ahtee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

2.  Different effects of chronic nicotine treatment regimens on body weight and tolerance in the rat.

Authors:  M M Morgan; G Ellison
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.